Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
EAU Guidelines on Prostate Cancer
20072.4k citationsAxel Heidenreich, M. Bolla et al.European Urologyprofile →
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
20042.2k citationsJacques Bernier, M. Bolla et al.profile →
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
20131.5k citationsAxel Heidenreich, M. Bolla et al.European Urologyprofile →
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
20021.3k citationsM. Bolla, Laurence Collette et al.The Lancetprofile →
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
19971.2k citationsM. Bolla, Jacques Bernier et al.profile →
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease
20101.2k citationsAxel Heidenreich, M. Bolla et al.European Urologyprofile →
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
20161.1k citationsM. Bolla, Steven Joniau et al.European Urologyprofile →
Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)
2005835 citationsM. Bolla, Hendrik Van Poppel et al.The Lancetprofile →
2011741 citationsA Heidenreich, J Bellmunt et al.European Urologyprofile →
Duration of Androgen Suppression in the Treatment of Prostate Cancer
2009658 citationsM. Bolla, Geertjan van Tienhoven et al.profile →
Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma
2002657 citationsDesmond Curran, M. Bolla et al.profile →
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
2010648 citationsM. Bolla, Geertjan van Tienhoven et al.profile →
Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
2012560 citationsM. Bolla, Hendrik Van Poppel et al.The Lancetprofile →
Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study
2014505 citationsJean-François Bosset, M. Bolla et al.profile →
Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
1992496 citationsM. Bolla et al.Radiotherapy and Oncologyprofile →
EAU Guidelines on Prostate Cancer
2005475 citationsGunna Aus, M. Bolla et al.European Urologyprofile →
This map shows the geographic impact of M. Bolla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Bolla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Bolla more than expected).
This network shows the impact of papers produced by M. Bolla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Bolla. The network helps show where M. Bolla may publish in the future.
Co-authorship network of co-authors of M. Bolla
This figure shows the co-authorship network connecting the top 25 collaborators of M. Bolla.
A scholar is included among the top collaborators of M. Bolla based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with M. Bolla. M. Bolla is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Bolla, M. & Hendrik Van Poppel. (2012). Management of prostate cancer : a multidisciplinary approach. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)).6 indexed citations
4.
Bolla, M., Hendrik Van Poppel, Bertrand Tombal, et al.. (2012). Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911). The Lancet. 380(9858). 2018–2027.560 indexed citations breakdown →
Baumann, Michaël, M. Bolla, Jean‐Luc Descotes, et al.. (2011). Prosper: image and robot-guided prostate brachytherapy. arXiv (Cornell University).1 indexed citations
8.
Heidenreich, Axel, Gunna Aus, M. Bolla, et al.. (2009). Review: EAU Guidelines on Prostate Cancer. Actas Urológicas Españolas. 33(2). 113–126.1 indexed citations
9.
Joniau, Steven, Lodovico Balducci, M. Bolla, et al.. (2008). SIOG (INTERNATIONAL SOCIETY OF GERIATRIC ONCOLOGY). European Urology Supplements. 7(3). 300.1 indexed citations
10.
Droz, Jean‐Pierre, Lodovico Balducci, M. Bolla, et al.. (2007). SIOG (International Society of Geriatric Oncology) prostate cancer guidelines proposals in senior adult men. European Journal of Cancer Supplements. 5(4). 175.3 indexed citations
Bolla, M., Hendrik Van Poppel, Laurence Collette, et al.. (2005). EORTC trial 22911: Immediate post-prostatectomy irradiation improves biochemical and clinical progression-free survival in patients with pathologically high risk prostate cancer. European Journal of Cancer Supplements. 3(2). 230–230.1 indexed citations
Vuillez, Jean‐Philippe, et al.. (1997). Evaluation of the diagnosis usefulness of OC125 immunoscintigraphy for ovarian carcinomas follow-up after treatment: contribution of this technique in the CHU of Grenoble. Bulletin du Cancer. 84(11).1 indexed citations
17.
Moro, Denis, Hélène Nagy-Mignotte, M. Bolla, et al.. (1997). Evaluation of survival and prognostic factors in 2,000 broncho-pulmonary cancers registered during 10 years in an oncology department. Bulletin du Cancer. 84(2).6 indexed citations
18.
Vuillez, J.-P., et al.. (1997). [Evaluation of the diagnostic usefulness of CA125 immunoscintigraphy for ovarian carcinoma follow-up after treatment: contribution of this technique in Grenoble University Medical Center].. PubMed. 84(11). 1033–42.3 indexed citations
19.
Bolla, M., et al.. (1990). [Causes of failure in the curative treatment of cancer of the exocrine pancreas].. PubMed. 77(3). 299–304.1 indexed citations
20.
Allain, Y., M. Bolla, D. Brune, et al.. (1987). Prostate cancer: results of radiotherapy in French cancer institutes.. PubMed. 243B. 121–39.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.